Tuesday, November 22, 2011

Ireland Faces $26B Headache as Drug Exports Fall - Bloomberg

Five of the world’s top-selling dozen medicines are produced in Ireland, and their sales will fall 52 percent to $13 billion by 2013 from $27 billion in 2010 as their patents expire, according to data compiled by Bloomberg based on analysts’ estimates. They start with Pfizer Inc. (PFE)’s cholesterol treatment Lipitor, which loses its patent protection this month.

Posted via email from Jack's posterous

No comments: